周昌明, 郭天安, 莫 淼, et al. Survival report of 13.7 thousand surgical colorectal cancer patients from a large single hospital-based cancer registry[J]. China Oncology, 2020, 30(4): 246-253.
周昌明, 郭天安, 莫 淼, et al. Survival report of 13.7 thousand surgical colorectal cancer patients from a large single hospital-based cancer registry[J]. China Oncology, 2020, 30(4): 246-253. DOI: 10.19401/j.cnki.1007-3639.2020.04.002.
3- and 5-year observed overall survival (OS) and disease-free survival (DFS)
providing real world evidence of long-term survival among Chinese surgical colorectal cancer patients. Methods: A total of 13 721 colorectal cancer patients undergoing surgery in Fudan University Shanghai Cancer Center (FUSCC) from Jan. 1
2008 to Dec. 31
2017 were included in the analysis. Medical records review
telephone visits and death registry data linkage were carried out for collecting endpoint data. The last follow-up date was Nov. 30
2019. Kaplan-Meier method was used to evaluate the 1-
3-
and 5-year OS and DFS
and data were stratified by age group
gender
staging
calendar period
pathological characteristics and treatment approaches. Results: With a median follow-up time of 54.03 months
the 5-year OS of all patients and DFS of 0-Ⅲ stage surgical colorectal cancer patients were 73.87% and 72.25%
respectively. The 5-year OS of stage 0-Ⅰ
Ⅱ
Ⅲ and Ⅳ colorectal cancer patients were 91.92%
87.15%
70.49% and 27.70%
respectively. The OS of patients aged less than 45 years was 74.93%
poorer than 45-64 and 65-74 age category. There were significant difference in OS and DFS among different histology types
differentiation
extermural vascular invasion
perineural invasion and circumferential radial margin. Conclusion: It is the first single institutional long term survival report of over 10 thousand colorectal cancer patients. Young patients aged less than 45 years had a poor prognosis. Staging is an important modifiable factor
which implies that enhancing screening and early diagnosis has important meaning to further improve the patients’ survival.